Economic Burden of Rheumatoid Arthritis In Iran: A Societal Perspective Economic Burden of R.A. Article Swipe
Mehdi Rezaee
,
Farhad Hosseinzadeh Lotfı
,
Ahmad Gholami
,
Jassem Azizpoor
,
Elham Aflaki
,
Afsaneh Vazin
,
Khosro Keshavarz
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-1275686/v1
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-1275686/v1
Background : Rheumatoid arthritis (RA) is a progressive, chronic systemic inflammatory disease and impose a significant economic burden on patients and societies if not controlled. This study aimed to determine the economic burden of RA in southern Iran in 2019. Methods : This economic burden study was carried out as cross-sectional research in 2019 in southern Iran, in which 765 patients were included. The prevalence-based and bottom-up approaches were also used to prepare the cost information and calculate the costs, respectively. The human capital approach was used to calculate the indirect costs as well. Results : The results showed that the economic burden of RA in Iran was $ 3,744,967,993 PPP in 2019. In addition, the mean annual costs of RA per patient in remission, low, and moderate-to severe states and the total cost were $ 11,925.98, $ 11,887.49, $ 12,803.45, and $ 12,155.08 PPP, respectively in 2019. Conclusions : RA imposed a significant economic burden on the community and patients, and DMC, especially the cost of drugs, were the most important component. It is suggested to provide necessary facilities to produce RA drugs in the country and expand home care services in order to reduce the economic burden.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.21203/rs.3.rs-1275686/v1
- https://www.researchsquare.com/article/rs-1275686/latest.pdf
- OA Status
- green
- Cited By
- 1
- References
- 29
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4206402685
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4206402685Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21203/rs.3.rs-1275686/v1Digital Object Identifier
- Title
-
Economic Burden of Rheumatoid Arthritis In Iran: A Societal Perspective Economic Burden of R.A.Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-01-20Full publication date if available
- Authors
-
Mehdi Rezaee, Farhad Hosseinzadeh Lotfı, Ahmad Gholami, Jassem Azizpoor, Elham Aflaki, Afsaneh Vazin, Khosro KeshavarzList of authors in order
- Landing page
-
https://doi.org/10.21203/rs.3.rs-1275686/v1Publisher landing page
- PDF URL
-
https://www.researchsquare.com/article/rs-1275686/latest.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.researchsquare.com/article/rs-1275686/latest.pdfDirect OA link when available
- Concepts
-
Rheumatoid arthritis, Economic cost, Medicine, Indirect costs, Disease burden, Economic impact analysis, Burden of disease, Environmental health, Cross-sectional study, Disease, Internal medicine, Business, Economics, Neoclassical economics, Microeconomics, Pathology, AccountingTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
29Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4206402685 |
|---|---|
| doi | https://doi.org/10.21203/rs.3.rs-1275686/v1 |
| ids.doi | https://doi.org/10.21203/rs.3.rs-1275686/v1 |
| ids.openalex | https://openalex.org/W4206402685 |
| fwci | 0.25168204 |
| type | preprint |
| title | Economic Burden of Rheumatoid Arthritis In Iran: A Societal Perspective Economic Burden of R.A. |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10200 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9314000010490417 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2745 |
| topics[0].subfield.display_name | Rheumatology |
| topics[0].display_name | Rheumatoid Arthritis Research and Therapies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777575956 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8068062663078308 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q187255 |
| concepts[0].display_name | Rheumatoid arthritis |
| concepts[1].id | https://openalex.org/C145096142 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7161720991134644 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5333450 |
| concepts[1].display_name | Economic cost |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6859907507896423 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C6964187 |
| concepts[3].level | 2 |
| concepts[3].score | 0.672291100025177 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q659256 |
| concepts[3].display_name | Indirect costs |
| concepts[4].id | https://openalex.org/C2780664029 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6110837459564209 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q5282120 |
| concepts[4].display_name | Disease burden |
| concepts[5].id | https://openalex.org/C188897 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5761575102806091 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5333508 |
| concepts[5].display_name | Economic impact analysis |
| concepts[6].id | https://openalex.org/C3020448403 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5223435163497925 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q5282120 |
| concepts[6].display_name | Burden of disease |
| concepts[7].id | https://openalex.org/C99454951 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4542766213417053 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[7].display_name | Environmental health |
| concepts[8].id | https://openalex.org/C142052008 |
| concepts[8].level | 2 |
| concepts[8].score | 0.44224172830581665 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q954027 |
| concepts[8].display_name | Cross-sectional study |
| concepts[9].id | https://openalex.org/C2779134260 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4091624617576599 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[9].display_name | Disease |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.23285618424415588 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C144133560 |
| concepts[11].level | 0 |
| concepts[11].score | 0.22942984104156494 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[11].display_name | Business |
| concepts[12].id | https://openalex.org/C162324750 |
| concepts[12].level | 0 |
| concepts[12].score | 0.16446653008460999 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[12].display_name | Economics |
| concepts[13].id | https://openalex.org/C133425853 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q60571 |
| concepts[13].display_name | Neoclassical economics |
| concepts[14].id | https://openalex.org/C175444787 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q39072 |
| concepts[14].display_name | Microeconomics |
| concepts[15].id | https://openalex.org/C142724271 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[15].display_name | Pathology |
| concepts[16].id | https://openalex.org/C121955636 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q4116214 |
| concepts[16].display_name | Accounting |
| keywords[0].id | https://openalex.org/keywords/rheumatoid-arthritis |
| keywords[0].score | 0.8068062663078308 |
| keywords[0].display_name | Rheumatoid arthritis |
| keywords[1].id | https://openalex.org/keywords/economic-cost |
| keywords[1].score | 0.7161720991134644 |
| keywords[1].display_name | Economic cost |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6859907507896423 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/indirect-costs |
| keywords[3].score | 0.672291100025177 |
| keywords[3].display_name | Indirect costs |
| keywords[4].id | https://openalex.org/keywords/disease-burden |
| keywords[4].score | 0.6110837459564209 |
| keywords[4].display_name | Disease burden |
| keywords[5].id | https://openalex.org/keywords/economic-impact-analysis |
| keywords[5].score | 0.5761575102806091 |
| keywords[5].display_name | Economic impact analysis |
| keywords[6].id | https://openalex.org/keywords/burden-of-disease |
| keywords[6].score | 0.5223435163497925 |
| keywords[6].display_name | Burden of disease |
| keywords[7].id | https://openalex.org/keywords/environmental-health |
| keywords[7].score | 0.4542766213417053 |
| keywords[7].display_name | Environmental health |
| keywords[8].id | https://openalex.org/keywords/cross-sectional-study |
| keywords[8].score | 0.44224172830581665 |
| keywords[8].display_name | Cross-sectional study |
| keywords[9].id | https://openalex.org/keywords/disease |
| keywords[9].score | 0.4091624617576599 |
| keywords[9].display_name | Disease |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.23285618424415588 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/business |
| keywords[11].score | 0.22942984104156494 |
| keywords[11].display_name | Business |
| keywords[12].id | https://openalex.org/keywords/economics |
| keywords[12].score | 0.16446653008460999 |
| keywords[12].display_name | Economics |
| language | en |
| locations[0].id | doi:10.21203/rs.3.rs-1275686/v1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402450 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Research Square (Research Square) |
| locations[0].source.host_organization | https://openalex.org/I4210096694 |
| locations[0].source.host_organization_name | Research Square (United States) |
| locations[0].source.host_organization_lineage | https://openalex.org/I4210096694 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.researchsquare.com/article/rs-1275686/latest.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.21203/rs.3.rs-1275686/v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5029454550 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2241-4402 |
| authorships[0].author.display_name | Mehdi Rezaee |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I194604659 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Medical Sciences Farhad Lot Shiraz University of Medical Sciences |
| authorships[0].institutions[0].id | https://openalex.org/I194604659 |
| authorships[0].institutions[0].ror | https://ror.org/01n3s4692 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I194604659 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | Shiraz University of Medical Sciences |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mehdi Rezaee |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University of Medical Sciences Farhad Lot Shiraz University of Medical Sciences |
| authorships[1].author.id | https://openalex.org/A5019808431 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5022-553X |
| authorships[1].author.display_name | Farhad Hosseinzadeh Lotfı |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I194604659 |
| authorships[1].affiliations[0].raw_affiliation_string | Shiraz University of Medical Sciences |
| authorships[1].institutions[0].id | https://openalex.org/I194604659 |
| authorships[1].institutions[0].ror | https://ror.org/01n3s4692 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I194604659 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Shiraz University of Medical Sciences |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Farhad Lotfi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Shiraz University of Medical Sciences |
| authorships[2].author.id | https://openalex.org/A5053819107 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1851-159X |
| authorships[2].author.display_name | Ahmad Gholami |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I194604659 |
| authorships[2].affiliations[0].raw_affiliation_string | Shiraz University of Medical Sciences Jassem Azizpoor Shiraz University of Medical Science |
| authorships[2].institutions[0].id | https://openalex.org/I194604659 |
| authorships[2].institutions[0].ror | https://ror.org/01n3s4692 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I194604659 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Shiraz University of Medical Sciences |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ahmad Gholami |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Shiraz University of Medical Sciences Jassem Azizpoor Shiraz University of Medical Science |
| authorships[3].author.id | https://openalex.org/A5089530057 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Jassem Azizpoor |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I166459259 |
| authorships[3].affiliations[0].raw_affiliation_string | Shiraz University of Medical Science |
| authorships[3].institutions[0].id | https://openalex.org/I166459259 |
| authorships[3].institutions[0].ror | https://ror.org/028qtbk54 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I166459259 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | Shiraz University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jassem Azizpoor |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Shiraz University of Medical Science |
| authorships[4].author.id | https://openalex.org/A5079123701 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1191-1494 |
| authorships[4].author.display_name | Elham Aflaki |
| authorships[4].countries | IR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I194604659 |
| authorships[4].affiliations[0].raw_affiliation_string | Shiraz University of Medical Sciences Afsaneh Vazin Shiraz University of Medical Sciences |
| authorships[4].institutions[0].id | https://openalex.org/I194604659 |
| authorships[4].institutions[0].ror | https://ror.org/01n3s4692 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I194604659 |
| authorships[4].institutions[0].country_code | IR |
| authorships[4].institutions[0].display_name | Shiraz University of Medical Sciences |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Elham Aflaki |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Shiraz University of Medical Sciences Afsaneh Vazin Shiraz University of Medical Sciences |
| authorships[5].author.id | https://openalex.org/A5020603813 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2230-4449 |
| authorships[5].author.display_name | Afsaneh Vazin |
| authorships[5].countries | IR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I194604659 |
| authorships[5].affiliations[0].raw_affiliation_string | Shiraz University of Medical Sciences |
| authorships[5].institutions[0].id | https://openalex.org/I194604659 |
| authorships[5].institutions[0].ror | https://ror.org/01n3s4692 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I194604659 |
| authorships[5].institutions[0].country_code | IR |
| authorships[5].institutions[0].display_name | Shiraz University of Medical Sciences |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Afsaneh Vazin |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Shiraz University of Medical Sciences |
| authorships[6].author.id | https://openalex.org/A5071078396 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-5778-5502 |
| authorships[6].author.display_name | Khosro Keshavarz |
| authorships[6].countries | IR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I194604659 |
| authorships[6].affiliations[0].raw_affiliation_string | Shiraz University of Medical Sciences |
| authorships[6].institutions[0].id | https://openalex.org/I194604659 |
| authorships[6].institutions[0].ror | https://ror.org/01n3s4692 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I194604659 |
| authorships[6].institutions[0].country_code | IR |
| authorships[6].institutions[0].display_name | Shiraz University of Medical Sciences |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Khosro Keshavarz |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Shiraz University of Medical Sciences |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.researchsquare.com/article/rs-1275686/latest.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Economic Burden of Rheumatoid Arthritis In Iran: A Societal Perspective Economic Burden of R.A. |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10200 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9314000010490417 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2745 |
| primary_topic.subfield.display_name | Rheumatology |
| primary_topic.display_name | Rheumatoid Arthritis Research and Therapies |
| related_works | https://openalex.org/W840339242, https://openalex.org/W2247645155, https://openalex.org/W1586321932, https://openalex.org/W4377724320, https://openalex.org/W2988766466, https://openalex.org/W2391461139, https://openalex.org/W4205727429, https://openalex.org/W2145151017, https://openalex.org/W4386200104, https://openalex.org/W4220746113 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.21203/rs.3.rs-1275686/v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402450 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Research Square (Research Square) |
| best_oa_location.source.host_organization | https://openalex.org/I4210096694 |
| best_oa_location.source.host_organization_name | Research Square (United States) |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I4210096694 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.researchsquare.com/article/rs-1275686/latest.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-1275686/v1 |
| primary_location.id | doi:10.21203/rs.3.rs-1275686/v1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402450 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Research Square (Research Square) |
| primary_location.source.host_organization | https://openalex.org/I4210096694 |
| primary_location.source.host_organization_name | Research Square (United States) |
| primary_location.source.host_organization_lineage | https://openalex.org/I4210096694 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.researchsquare.com/article/rs-1275686/latest.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-1275686/v1 |
| publication_date | 2022-01-20 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W1857415954, https://openalex.org/W2623614354, https://openalex.org/W2608603956, https://openalex.org/W1976795389, https://openalex.org/W2086696463, https://openalex.org/W2119138901, https://openalex.org/W2904284152, https://openalex.org/W3011532946, https://openalex.org/W2568119991, https://openalex.org/W2588618693, https://openalex.org/W183185859, https://openalex.org/W2158003651, https://openalex.org/W2532257978, https://openalex.org/W2998075516, https://openalex.org/W7073565537, https://openalex.org/W1529096567, https://openalex.org/W2152734154, https://openalex.org/W2546668519, https://openalex.org/W2126477984, https://openalex.org/W2018267132, https://openalex.org/W1984009427, https://openalex.org/W2149026148, https://openalex.org/W2165073603, https://openalex.org/W3152044313, https://openalex.org/W3092065440, https://openalex.org/W1685652819, https://openalex.org/W1968056291, https://openalex.org/W2102273617, https://openalex.org/W1980049401 |
| referenced_works_count | 29 |
| abstract_inverted_index.$ | 109, 136, 138, 140, 143 |
| abstract_inverted_index.: | 2, 42, 96, 150 |
| abstract_inverted_index.a | 7, 15, 153 |
| abstract_inverted_index.In | 114 |
| abstract_inverted_index.It | 174 |
| abstract_inverted_index.RA | 35, 105, 121, 151, 183 |
| abstract_inverted_index.as | 50, 93 |
| abstract_inverted_index.if | 23 |
| abstract_inverted_index.in | 36, 39, 53, 55, 58, 106, 112, 124, 147, 185, 193 |
| abstract_inverted_index.is | 6, 175 |
| abstract_inverted_index.of | 34, 104, 120, 167 |
| abstract_inverted_index.on | 19, 157 |
| abstract_inverted_index.to | 29, 72, 88, 177, 181, 195 |
| abstract_inverted_index.765 | 60 |
| abstract_inverted_index.PPP | 111 |
| abstract_inverted_index.The | 64, 82, 97 |
| abstract_inverted_index.and | 13, 21, 66, 77, 127, 131, 142, 160, 162, 188 |
| abstract_inverted_index.not | 24 |
| abstract_inverted_index.out | 49 |
| abstract_inverted_index.per | 122 |
| abstract_inverted_index.the | 31, 74, 79, 90, 101, 116, 132, 158, 165, 170, 186, 197 |
| abstract_inverted_index.was | 47, 86, 108 |
| abstract_inverted_index.(RA) | 5 |
| abstract_inverted_index.2019 | 54 |
| abstract_inverted_index.DMC, | 163 |
| abstract_inverted_index.Iran | 38, 107 |
| abstract_inverted_index.PPP, | 145 |
| abstract_inverted_index.This | 26, 43 |
| abstract_inverted_index.also | 70 |
| abstract_inverted_index.care | 191 |
| abstract_inverted_index.cost | 75, 134, 166 |
| abstract_inverted_index.home | 190 |
| abstract_inverted_index.low, | 126 |
| abstract_inverted_index.mean | 117 |
| abstract_inverted_index.most | 171 |
| abstract_inverted_index.that | 100 |
| abstract_inverted_index.used | 71, 87 |
| abstract_inverted_index.were | 62, 69, 135, 169 |
| abstract_inverted_index.2019. | 40, 113, 148 |
| abstract_inverted_index.Iran, | 57 |
| abstract_inverted_index.aimed | 28 |
| abstract_inverted_index.costs | 92, 119 |
| abstract_inverted_index.drugs | 184 |
| abstract_inverted_index.human | 83 |
| abstract_inverted_index.order | 194 |
| abstract_inverted_index.study | 27, 46 |
| abstract_inverted_index.total | 133 |
| abstract_inverted_index.well. | 94 |
| abstract_inverted_index.which | 59 |
| abstract_inverted_index.annual | 118 |
| abstract_inverted_index.burden | 18, 33, 45, 103, 156 |
| abstract_inverted_index.costs, | 80 |
| abstract_inverted_index.drugs, | 168 |
| abstract_inverted_index.expand | 189 |
| abstract_inverted_index.impose | 14 |
| abstract_inverted_index.reduce | 196 |
| abstract_inverted_index.severe | 129 |
| abstract_inverted_index.showed | 99 |
| abstract_inverted_index.states | 130 |
| abstract_inverted_index.Methods | 41 |
| abstract_inverted_index.Results | 95 |
| abstract_inverted_index.burden. | 199 |
| abstract_inverted_index.capital | 84 |
| abstract_inverted_index.carried | 48 |
| abstract_inverted_index.chronic | 9 |
| abstract_inverted_index.country | 187 |
| abstract_inverted_index.disease | 12 |
| abstract_inverted_index.imposed | 152 |
| abstract_inverted_index.patient | 123 |
| abstract_inverted_index.prepare | 73 |
| abstract_inverted_index.produce | 182 |
| abstract_inverted_index.provide | 178 |
| abstract_inverted_index.results | 98 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.approach | 85 |
| abstract_inverted_index.economic | 17, 32, 44, 102, 155, 198 |
| abstract_inverted_index.indirect | 91 |
| abstract_inverted_index.patients | 20, 61 |
| abstract_inverted_index.research | 52 |
| abstract_inverted_index.services | 192 |
| abstract_inverted_index.southern | 37, 56 |
| abstract_inverted_index.systemic | 10 |
| abstract_inverted_index.12,155.08 | 144 |
| abstract_inverted_index.addition, | 115 |
| abstract_inverted_index.arthritis | 4 |
| abstract_inverted_index.bottom-up | 67 |
| abstract_inverted_index.calculate | 78, 89 |
| abstract_inverted_index.community | 159 |
| abstract_inverted_index.determine | 30 |
| abstract_inverted_index.important | 172 |
| abstract_inverted_index.included. | 63 |
| abstract_inverted_index.necessary | 179 |
| abstract_inverted_index.patients, | 161 |
| abstract_inverted_index.societies | 22 |
| abstract_inverted_index.suggested | 176 |
| abstract_inverted_index.11,887.49, | 139 |
| abstract_inverted_index.11,925.98, | 137 |
| abstract_inverted_index.12,803.45, | 141 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Rheumatoid | 3 |
| abstract_inverted_index.approaches | 68 |
| abstract_inverted_index.component. | 173 |
| abstract_inverted_index.especially | 164 |
| abstract_inverted_index.facilities | 180 |
| abstract_inverted_index.remission, | 125 |
| abstract_inverted_index.Conclusions | 149 |
| abstract_inverted_index.controlled. | 25 |
| abstract_inverted_index.information | 76 |
| abstract_inverted_index.moderate-to | 128 |
| abstract_inverted_index.significant | 16, 154 |
| abstract_inverted_index.inflammatory | 11 |
| abstract_inverted_index.progressive, | 8 |
| abstract_inverted_index.respectively | 146 |
| abstract_inverted_index.3,744,967,993 | 110 |
| abstract_inverted_index.respectively. | 81 |
| abstract_inverted_index.cross-sectional | 51 |
| abstract_inverted_index.prevalence-based | 65 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5071078396 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I194604659 |
| citation_normalized_percentile.value | 0.47489227 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |